[Profitability of the radiological examination of the thorax. Development of thoracic radiology, administered dose, quality control and role of the clinic].
The considerable spreading of chest X-ray (about 50% of all radiological examinations--WHO official report No. 698), and its biological and economic high cost, make interesting the cost/benefit evaluation of this simple and world-wide X-ray examination. The evaluation, highly important although very complex, is concerned with many different problems. The different problems, such as the development of radiological diagnosis in pulmonary diseases, dose of exposure, quality assurance and clinical role are analyzed.